Related Experiment Video

Updated: May 26, 2026

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
09:22

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Published on: April 2, 2017

QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?

Mauro Bernardi1, Caterina Maggioli, Valmir Dibra

  • 1Unità Operativa Semeiotica Medica, Department of Clinical Medicine, Alma Mater Studiorum University of Bologna, Via Albertoni 15, Bologna 40138, Italy. mauro.bernardi@unibo.it

Expert Review of Gastroenterology & Hepatology
|December 14, 2011
PubMed

Insights

Prolonged QT interval in liver cirrhosis patients indicates delayed repolarization, increasing arrhythmia and sudden death risk. This hallmark of cirrhotic cardiomyopathy warrants further investigation into its mechanisms and clinical implications.

Area of Science:

  • Cardiology
  • Hepatology
  • Electrophysiology

Background:

  • The QT interval on an electrocardiogram (ECG) reflects ventricular repolarization.
  • Prolonged QT interval is linked to increased risk of ventricular arrhythmias and sudden cardiac death.
  • Cardiac electrophysiological abnormalities are common in liver cirrhosis, with prolonged QT interval being a key feature of cirrhotic cardiomyopathy.

Purpose of the Study:

  • To review the epidemiology of QT interval prolongation in liver cirrhosis.
  • To explore molecular mechanisms and the role of cardiotoxins in the pathogenesis of this abnormality.
  • To discuss the prognostic significance and clinical relevance of prolonged QT interval in cirrhotic patients.

Main Methods:

  • Literature review focusing on QT interval prolongation in liver cirrhosis.
  • Analysis of epidemiological data, molecular mechanisms, and prognostic implications.
  • Examination of clinical relevance concerning drug interactions and stressful conditions.

Main Results:

  • QT interval prolongation is a recognized electrophysiological abnormality in liver cirrhosis.
  • Potential molecular mechanisms and cardiotoxins are implicated in its development.
  • A prolonged QT interval has prognostic significance and clinical relevance in cirrhotic patients.

Conclusions:

  • Prolonged QT interval is the electrophysiological hallmark of cirrhotic cardiomyopathy.
  • Understanding its mechanisms, prognosis, and clinical associations is crucial for patient management.
  • Further research is needed to elucidate the full clinical impact in this patient population.

More Related Videos

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...